Synapse - Works

Results (115370)

TBCRC 058: A randomized phase II study of enzalutamide, enzalutamide with mifepristone, and treatment of physician's choice in patients with androgen receptor-positive metastatic triple-negative or estrogen receptor-low breast cancer (NCT06099769)

Meeting Abstract

Traina, T. A.; Chen, Y.; Khoury, K.; Rugo, H. S.; Mayer, E. L.; Carey, L. A.; Melisko, M. E.; Syldor, A.; Friedman, C.; Savoie, J.; more...
Journal of Clinical Oncology (2024)

Fulltext@MSK | Save

A first-in-human phase 1 trial of dose escalating intrathecal (IT) dendritic cells (cDC1s) primed against HER2/HER3 in patients (pts) with leptomeningeal disease (LMD) from triple-negative (TNBC) or HER2+ breast cancer (BC)

Meeting Abstract

Forsyth, P. A. J.; Gandhi, S.; Wilcox, J.; Law, V.; Mo, Q.; Chen, Z.; Ahmed, K. A.; Piteo, C.; Evernden, B.; Pina, Y.; more...
Journal of Clinical Oncology (2024)

Fulltext@MSK | Save

Updated quality-adjusted time without symptoms or toxicity (Q-TWiST) analysis of nivolumab plus chemotherapy versus chemotherapy alone as first-line (1L) treatment for advanced gastric cancer, gastroesophageal junction cancer, or esophageal adenocarcinoma (GC/GEJC/EAC): 4-year (yr) follow-up from CheckMate 649 (CM 649)

Meeting Abstract

Lin, D.; Quan, W.; Garretson, M.; Chirikov, V.; Chen, C.; Singh, P.; Davis, C.; Sugarman, R.
Journal of Clinical Oncology (2024)

Fulltext@MSK | Save

Implementing financial toxicity and health-related social risks screening and referral

Meeting Abstract

Thom, B.; Aviki, E. M.; Chino, F.
Journal of Clinical Oncology (2024)

Fulltext@MSK | Save

Glucagon-like peptide-1 (GLP-1) agonist use and weight change among patients with breast cancer

Meeting Abstract

Shen, S.; Liu, B.; Fanti, C.; Bromberg, M.; Chen, Y.; Chang, C.; Iyengar, N. M.
Journal of Clinical Oncology (2024)

Fulltext@MSK | Save

A multi-institution analysis of outcomes with first-line systemic therapy for 99 patients with metastatic chromophobe renal cell carcinoma

Meeting Abstract

Doshi, S. D.; Dizman, N.; Knezevic, A.; Touma, A.; Alaghehbandan, R.; Ged, Y.; Ornstein, M. C.; Hahn, A. W.; Msaouel, P.; Voss, M. H.
Journal of Clinical Oncology (2024)

Fulltext@MSK | Save

Endometrial carcinoma in Black vs Asian women: Racial disparities and opportunities to improve survival in 219,301 patients in the USA

Meeting Abstract

Becerra, H. A.; Ilerhunmwuwa, N. P.; Wasifuddin, M.; Uche, I.; Osorio, J. C.; Wang, J. C. C.
Journal of Clinical Oncology (2024)

Fulltext@MSK | Save

Real world outcomes of sequential ADC therapy in metastatic breast cancer: Patients treated with sacituzumab govitecan and trastuzumab deruxtecan

Meeting Abstract

Mai, N.; Klar, M.; Ferraro, E.; Bromberg, M.; Chen, Y.; Razavi, P.; Modi, S.; Chandarlapaty, S.; Walsh, E. M.; Drago, J. Z.
Journal of Clinical Oncology (2024)

Fulltext@MSK | Save

Cancer care service use intensity in Medicare Advantage versus traditional Medicare

Meeting Abstract

Mitchell, A. P.; Kalidindi, Y.; Feldman, R.; Carlin, C.; Song, G.; Jung, J.
Journal of Clinical Oncology (2024)

Fulltext@MSK | Save

TAZNI: A phase I/II combination trial of tazemetostat with nivolumab and ipilimumab for children with INI1-negative or SMARCA4-deficient tumors

Meeting Abstract

Yi, J. S.; Czaplinski, J.; Bhushan, K.; Forrest, S. J.; Shukla, N.; Mack, S. C.; Hong, A. L.; Kentsis, A.; Stinehart, M.; Ezrre, S.; more...
Journal of Clinical Oncology (2024)

Fulltext@MSK | Save